The Role of the Immune System in Nevirapine-Induced Subclinical Liver Injury of a Rat Model
Figure 4
Serum concentrations (mean ± SD) of IL-2 (a), IFN- (b), TNF- (c) and nevirapine (NVP), (d), in rats treated daily with NVP, but 24 hours after challenge with saline (S; S + NVP) or lipopolysaccharide (LPS; LPS + NVP) on days 7, 14 and 21 treatment. Note†: indicates that the values for the nevirapine-treated group (S + NVP) were significantly () different from those of the LPS + NVP group.